HomeComparePARNF vs QYLD

PARNF vs QYLD: Dividend Comparison 2026

PARNF yields 2500.00% · QYLD yields 11.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PARNF wins by $80609755877.34M in total portfolio value
10 years
PARNF
PARNF
● Live price
2500.00%
Share price
$0.08
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80609755877.37M
Annual income
$74,729,580,081,858,750.00
Full PARNF calculator →
QYLD
Global X Nasdaq 100 Covered Call ETF
● Live price
11.92%
Share price
$17.15
Annual div
$2.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.4K
Annual income
$5,659.31
Full QYLD calculator →

Portfolio growth — PARNF vs QYLD

📍 PARNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPARNFQYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PARNF + QYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PARNF pays
QYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PARNF
Annual income on $10K today (after 15% tax)
$212,500.00/yr
After 10yr DRIP, annual income (after tax)
$63,520,143,069,579,940.00/yr
QYLD
Annual income on $10K today (after 15% tax)
$1,013.51/yr
After 10yr DRIP, annual income (after tax)
$4,810.41/yr
At 15% tax rate, PARNF beats the other by $63,520,143,069,575,130.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PARNF + QYLD for your $10,000?

PARNF: 50%QYLD: 50%
100% QYLD50/50100% PARNF
Portfolio after 10yr
$40304877938.70M
Annual income
$37,364,790,040,932,210.00/yr
Blended yield
92.71%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PARNF buys
0
QYLD buys
0
No recent congressional trades found for PARNF or QYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPARNFQYLD
Forward yield2500.00%11.92%
Annual dividend / share$2.00$2.04
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$80609755877.37M$25.4K
Annual income after 10y$74,729,580,081,858,750.00$5,659.31
Total dividends collected$80198875900.38M$27.1K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: PARNF vs QYLD ($10,000, DRIP)

YearPARNF PortfolioPARNF Income/yrQYLD PortfolioQYLD Income/yrGap
1← crossover$260,700$250,000.00$10,352$1,192.36+$250.3KPARNF
2$6,370,070$6,091,121.50$10,830$1,347.57+$6.36MPARNF
3$145,912,632$139,096,656.81$11,460$1,539.07+$145.90MPARNF
4$3,133,830,814$2,977,704,297.75$12,275$1,777.84+$3133.82MPARNF
5$63,122,812,060$59,769,613,088.96$13,323$2,078.95+$63122.80MPARNF
6$1,192,683,724,131$1,125,142,315,226.76$14,667$2,463.34+$1192683.71MPARNF
7$21,144,559,711,004$19,868,388,126,183.19$16,396$2,960.57+$21144559.69MPARNF
8$351,818,906,448,043$329,194,227,557,269.44$18,631$3,612.97+$351818906.43MPARNF
9$5,495,491,397,671,320$5,119,045,167,771,913.00$21,548$4,482.15+$5495491397.65MPARNF
10$80,609,755,877,367,070$74,729,580,081,858,750.00$25,398$5,659.31+$80609755877.34MPARNF

PARNF vs QYLD: Complete Analysis 2026

PARNFStock

Parnell Pharmaceuticals Holdings Ltd, a commercial-stage pharmaceutical company, focuses on developing, manufacturing, and marketing animal pharmaceutical products worldwide. The company operates through four segments: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. It markets various products, including estroPLAN and GONAbreed reproductive hormone products for enhancing cattle breeding performance; Zydax for the treatment of osteoarthritis (OA) in dogs and horses; and Glyde, a nutraceutical product for the treatment of OA, as well as Parnell PROcept, which adds an additional injection of estroPLAN after the first injection. The company also offers mySYNCH, a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains. Parnell Pharmaceuticals Holdings Ltd was incorporated in 2009 and is headquartered in Alexandria, Australia.

Full PARNF Calculator →

QYLDETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →
📬

Get this PARNF vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PARNF vs SCHDPARNF vs JEPIPARNF vs OPARNF vs KOPARNF vs MAINPARNF vs XYLDPARNF vs JEPQPARNF vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.